NO308024B1 - Doseringsenhet omfattende tverrbundet polyhydroksylisk materiale for enzymatisk kontrollert medikamentfrigjøring - Google Patents

Doseringsenhet omfattende tverrbundet polyhydroksylisk materiale for enzymatisk kontrollert medikamentfrigjøring

Info

Publication number
NO308024B1
NO308024B1 NO950251A NO950251A NO308024B1 NO 308024 B1 NO308024 B1 NO 308024B1 NO 950251 A NO950251 A NO 950251A NO 950251 A NO950251 A NO 950251A NO 308024 B1 NO308024 B1 NO 308024B1
Authority
NO
Norway
Prior art keywords
amylase
alpha
dosage unit
crosslinked
drug release
Prior art date
Application number
NO950251A
Other languages
English (en)
Norwegian (no)
Other versions
NO950251D0 (no
NO950251L (no
Inventor
Mircea A Mateescu
Yves Dumoulin
Louis Cartilier
Vincent Lenaerts
Original Assignee
Labopharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Labopharm Inc filed Critical Labopharm Inc
Publication of NO950251D0 publication Critical patent/NO950251D0/no
Publication of NO950251L publication Critical patent/NO950251L/no
Publication of NO308024B1 publication Critical patent/NO308024B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2068—Compounds of unknown constitution, e.g. material from plants or animals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Botany (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO950251A 1992-07-24 1995-01-23 Doseringsenhet omfattende tverrbundet polyhydroksylisk materiale for enzymatisk kontrollert medikamentfrigjøring NO308024B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US91976292A 1992-07-24 1992-07-24
PCT/CA1993/000298 WO1994002121A1 (en) 1992-07-24 1993-07-22 Cross-linked polyhydroxylic material for enzymatically controlled drug release

Publications (3)

Publication Number Publication Date
NO950251D0 NO950251D0 (no) 1995-01-23
NO950251L NO950251L (no) 1995-01-23
NO308024B1 true NO308024B1 (no) 2000-07-10

Family

ID=25442612

Family Applications (1)

Application Number Title Priority Date Filing Date
NO950251A NO308024B1 (no) 1992-07-24 1995-01-23 Doseringsenhet omfattende tverrbundet polyhydroksylisk materiale for enzymatisk kontrollert medikamentfrigjøring

Country Status (18)

Country Link
EP (1) EP0651634B1 (hu)
JP (1) JP3647859B2 (hu)
KR (1) KR100304997B1 (hu)
AT (1) ATE137668T1 (hu)
AU (1) AU668198B2 (hu)
CA (1) CA2140032C (hu)
CZ (1) CZ283395B6 (hu)
DE (1) DE69302580T2 (hu)
ES (1) ES2086949T3 (hu)
FI (1) FI950301L (hu)
GR (1) GR3020476T3 (hu)
HU (1) HU221591B (hu)
MX (1) MX9304459A (hu)
NO (1) NO308024B1 (hu)
NZ (1) NZ254048A (hu)
PL (1) PL173249B1 (hu)
RU (1) RU2136270C1 (hu)
WO (1) WO1994002121A1 (hu)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2173818A1 (fr) * 1996-04-10 1997-10-11 Francois Chouinard Comprime pharmaceutique a liberation controlee contenant un support a base d'amylose reticule et d'hydroxypropylmethylcellulose
DE19640062B4 (de) 1996-09-28 2006-04-27 Lts Lohmann Therapie-Systeme Ag Orale Zubereitung, enthaltend in einer in wässrigem Medium quellbaren Matrix wenigstens einen pharmazeutischen Wirkstoff
US5879707A (en) * 1996-10-30 1999-03-09 Universite De Montreal Substituted amylose as a matrix for sustained drug release
US5807575A (en) * 1997-02-14 1998-09-15 Rougier Inc. Manufacture of cross-linked amylose useful as a excipient for control release of active compounds
WO1998052566A1 (en) * 1997-05-21 1998-11-26 Warner-Lambert Company Non-sedating acrivastine preparation
CA2217238C (en) * 1997-10-24 2005-09-20 Louis Cartilier Cross-linked cellulose as a tablet excipient
KR20020062323A (ko) 1999-12-06 2002-07-25 펜웨스트 파머슈티칼즈 컴파니 제약학적 초붕해제
US6607748B1 (en) 2000-06-29 2003-08-19 Vincent Lenaerts Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture
US8487002B2 (en) 2002-10-25 2013-07-16 Paladin Labs Inc. Controlled-release compositions
TWI319713B (en) 2002-10-25 2010-01-21 Sustained-release tramadol formulations with 24-hour efficacy
DK1940467T3 (da) 2005-09-09 2017-02-13 Paladin Labs Inc Lægemiddelsammensætning med langvarig frigivelse
US9029427B2 (en) 2005-11-11 2015-05-12 Asahi Kasei Chemicals Corporation Controlled release solid preparation
AR082189A1 (es) 2010-07-06 2012-11-21 Gruenenthal Gmbh Formas de dosificacion gastrorretentivas, procedimiento
AR082167A1 (es) 2010-07-14 2012-11-14 Gruenenthal Gmbh Formas de dosificacion gastrorretentivas

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3181998A (en) * 1960-08-12 1965-05-04 Joseph L Kanig Tablet disintegration
US3493652A (en) * 1962-09-14 1970-02-03 Charles W Hartman Controlled release medicament
SE420565B (sv) * 1974-06-06 1981-10-19 Pharmacia Ab Hjelpmedel for intravaskuler administraring for anvendning i samband med intravaskuler administrering av en losning eller en suspension av ett diagnostiseringsmedel
DE3721574A1 (de) * 1987-06-30 1989-01-12 Kettelhack Riker Pharma Gmbh Arzneimittel in form von pellets mit enzymatisch kontrollierter arzneistoff-freisetzung
IT1241417B (it) * 1990-03-06 1994-01-14 Vectorpharma Int Composizioni terapeutiche a rilascio controllato di farmaci supportatisu polimeri reticolati e rivestiti con film polimerici,e loro processodi preparazione

Also Published As

Publication number Publication date
NO950251D0 (no) 1995-01-23
ATE137668T1 (de) 1996-05-15
PL173249B1 (pl) 1998-02-27
FI950301A0 (fi) 1995-01-24
NO950251L (no) 1995-01-23
PL307234A1 (en) 1995-05-15
JPH08502036A (ja) 1996-03-05
EP0651634B1 (en) 1996-05-08
FI950301A7 (fi) 1995-01-24
EP0651634A1 (en) 1995-05-10
HU221591B (hu) 2002-11-28
AU668198B2 (en) 1996-04-26
CZ283395B6 (cs) 1998-04-15
RU2136270C1 (ru) 1999-09-10
KR100304997B1 (ko) 2002-04-24
DE69302580T2 (de) 1996-09-26
HUT75673A (en) 1997-05-28
FI950301L (fi) 1995-01-24
WO1994002121A1 (en) 1994-02-03
GR3020476T3 (en) 1996-10-31
CA2140032A1 (en) 1994-02-03
DE69302580D1 (de) 1996-06-13
CA2140032C (en) 1999-01-26
HU9500197D0 (en) 1995-03-28
ES2086949T3 (es) 1996-07-01
MX9304459A (es) 1994-04-29
CZ15295A3 (en) 1995-09-13
NZ254048A (en) 1995-09-26
AU4555993A (en) 1994-02-14
JP3647859B2 (ja) 2005-05-18

Similar Documents

Publication Publication Date Title
NO308024B1 (no) Doseringsenhet omfattende tverrbundet polyhydroksylisk materiale for enzymatisk kontrollert medikamentfrigjøring
NO953767D0 (no) Tverrbundet amylose som et binde-/opplösende middel i tabletter
DE69722247D1 (de) Pharmazeutische tablette mit verzögerter freisetzung, enthaltend eine matrix aus quervernetzter amylose und hydroxypropyl methylzellulose
NO20001042L (no) Oftalmiske preparater med forsinket frigivelse inneholdende vannoppløselige medikamenter
NO20004208D0 (no) Fornettet stivelse med høyt amyloseinnhold og med funksjonelle grupper som en matriks for frigivning av farmasøytiske midler
UA29400C2 (uk) Пластир для трансдермального введення нітрогліцерину та спосіб його виготовлення
ES2152979T3 (es) Sistema terapeutico transdermal que contiene estradiol.
NO964799D0 (no) Hydrofile kontakt-smelteklebemidler
AU4627096A (en) Pharmaceutical compositions in the form of slow release tablets based on high molecular weight polysaccharide granules
RU95107880A (ru) Твердая фармацевтическая форма
DE59504270D1 (de) Retardtablette mit einem gehalt an diclofenac-na
DE69225053D1 (de) Zusammensetzungen auf der basis von collagen zur kontrollierten arzneistoffreisetzung
DK0804165T3 (da) Fast lægemiddelform med aktivt stof fordelt i polymert materiale

Legal Events

Date Code Title Description
MK1K Patent expired